AGP Picks
View all

Bulletin | Federal Medical Cannabis Rescheduling and DEA Registration Information | November 18, 2026

News originally published by

Massachusetts Cannabis Control Commission

This bulletin is issued to Massachusetts licensed Marijuana Establishments and Medical Marijuana Establishments (Medical Marijuana Treatment Centers) (collectively, “licensees”).

The Cannabis Control Commission (Commission) continues to monitor recent federal developments regarding the treatment of medical cannabis under the federal Controlled Substances Act, including the U.S. Drug Enforcement Administration’s (DEA) implementation of a registration process for certain entities handling Schedule III medical cannabis.

Most recently, the DEA published information regarding certain entities that submitted applications for DEA registration to handle Schedule III medical cannabis. See information attached below. The Commission is sharing this information so that licensees have access to publicly available federal information.

The administration and enforcement of federal cannabis laws remain outside the Commission’s jurisdiction. The Commission has not received implementation guidance from any federal agencies regarding these developments and cannot provide guidance regarding DEA registration requirements or the interpretation or application of federal laws, regulations, or policies.

The Commission cannot provide legal, tax, or business advice regarding the impact of federal developments on individual licensees, registered entities, or other program participants. Businesses and individuals should consult their own attorneys, tax professionals, and other advisors regarding their specific circumstances.

The Commission will continue to administer and enforce Massachusetts cannabis laws and regulations, including G.L. c. 94G, G.L. c. 94I, and 935 CMR 500.000 and 501.000. Currently, these federal developments do not change the Commission’s administration of Massachusetts cannabis laws and regulations. Licensees remain responsible for complying with all applicable state requirements.

Resources

Provided for informational purposes only.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Need to Know CBD

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.